Metric Deep Dive: Understanding SELLAS Life Sciences Group Inc (SLS) Through its Ratios

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $1.09 in the prior trading day, SELLAS Life Sciences Group Inc (NASDAQ: SLS) closed at $1.14, up 4.59%. In other words, the price has increased by $4.59 from its previous closing price. On the day, 1.86 million shares were traded. SLS stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $1.08.

Ratios:

Our goal is to gain a better understanding of SLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.49 and its Current Ratio is at 1.49. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.

On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLS now has a Market Capitalization of 65840584 and an Enterprise Value of 48226616.

Stock Price History:

The Beta on a monthly basis for SLS is 2.39, which has changed by -0.34857142 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, SLS has reached a high of $1.90, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is -13.00%, while the 200-Day Moving Average is calculated to be 2.79%.

Shares Statistics:

The stock has traded on average 1.20M shares per day over the past 3-months and 717760 shares per day over the last 10 days, according to various share statistics. A total of 57.75M shares are outstanding, with a floating share count of 57.48M. Insiders hold about 0.48% of the company’s shares, while institutions hold 13.36% stake in the company. Shares short for SLS as of 1719532800 were 8859447 with a Short Ratio of 7.39, compared to 1717113600 on 7645067. Therefore, it implies a Short% of Shares Outstanding of 8859447 and a Short% of Float of 15.379999999999999.

Most Popular